Keywords: CTCL, cutaneous T-cell lymphoma(s); PCGD-TCL, primary cutaneous γδ T-cell lymphoma(s); cytotoxic T-cell lymphoma; dupilumab; primary cutaneous γδ T-cell lymphoma.